The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Icorvida SR 1.5mg Prolonged-release Tablets

KRKA, d.d., Novo mestoPA1347/022/001

Main Information

Trade NameIcorvida SR 1.5mg Prolonged-release Tablets
Active SubstancesIndapamide
Dosage FormProlonged-release tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/022/001

Group Information

ATC CodeC03BA Sulfonamides, plain
C03BA11 indapamide


License statusAuthorised
Licence Issued03/02/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back